Device Survival Probability
C5TR01_C6TR01_SURV
| 1 yr | 2 yr | 3 yr | at 37.0 mo | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| % |  |
100.0 | 100.0 | 100.0 | 100.0 | ||||||
| % |  |
99.9 | 99.9 | 99.4 | 98.7 | ||||||
| # | 6944 | 3384 | 313 | 140 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Advisories For This Model
- There are no advisories for this model.
Performance Notes For This Model
- There are no performance notes for this model.
Product Characteristics
| Generator Type | CRT-Pacing |
|---|---|
| NBD Code | OAE-DDDR |
| Max. Delivered Energy | N/A |
| Connector Style | CRT-P Style |
|---|---|
| Serial Number Prefix | PZZ |
| Mass | 26 g |
| Volume | 15 cc |
| Waveform | N/A |
| X-Ray ID | PVX |
Estimated Longevity
| Amplitude Setting | 500 Lead Ω | 1000 Lead Ω |
|---|---|---|
| Low 2.5 V (A, RV) | 8.5 | 10.4 |
| Nominal 3.5 V (A, RV) | 5.8 | 8.0 |
| High 5.0 V (A, RV) | 3.2 | 5.0 |
Longevity estimates based on the following device usage. Pace/Sense Mode DDD ; Atrial Pulse Width 0.4 ms; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; Upper Sensing Rate 130 ppm; Atrial Percent Paced 100 %; Left Ventricle Pulse Width 0.4 ms; Left Ventricle Pulse Amplitude same as A, RV; Left Ventricle Percent Paced 100 %; Left Ventricle Lead Impedance same as A, RV; EGM Prestorage ON ; EGM Prestorage ON Time 1 ; Atrial Fib Percent of Time 0 %Hide this content
Distribution Data
| US Market Release | |
|---|---|
| CE Approval Date | 2014-04-04 |
| Registered USA Implants | |
| Estimated Active USA Implants | |
| Normal Battery Depletions |
| US Market Release | |
|---|---|
| CE Approval Date | 2014-04-04 |
| Estimated WW Distribution | 9148 |
| Normal Battery Depletions |
Malfunctions (USA)
| Therapy Function Not Compromised | |
|---|---|
| Therapy Function Compromised |
Malfunctions (WW)
| Therapy Function Not Compromised | |
|---|---|
| Therapy Function Compromised |
EOS Indication
From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.
Elective Replacement (ERI)
Battery voltage less than or equal to 2.77V on 3 consecutive daily automatic measurements.
Data as of January 31, 2018